STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719) has released an update. Shandong Xinhua Pharmaceutical ...

In a recent discussion with Dr. Joe Dituri on Power Athlete Radio, we explored the significant risk posed by America’s dependence on foreign-made pharmaceutical ...

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance on Wednesday after beating third-quarter profit ...

Despite the relatively low profile, Tianjin Pharmaceutical's improved earnings have earned recognition from investors ...

Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...

Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $40.00 Call had some of the ...

“Chris is a talented finance executive with deep experience in the pharmaceutical sector, and we are pleased to welcome him to the Eagle team,” said Michael Graves, Interim Principal Executive Officer ...

With increasing pharmaceutical production and a growing focus on patient safety, the demand for specialized and customizable ...

ICU Medical (ICUI) and Otsuka Pharmaceutical Factory, global IV solutions manufacturing subsidiary of Otsuka Holdings Co., Ltd., together announce the creation of a joint venture to provide additional ...

Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment ...